Wednesday, November 09, 2022 3:45:43 PM
Yes—real science indeed! Steinman’s discovery of the DC cell won the Nobel Prize and cell-based technology is the future of oncology. What is most exciting is that the future is now…
Immunotherapy will address a global need for less toxic and more efficacious cancer treatment. FDA believes without question that cell-based science is worthy of their support and will ensure that the United States will lead the world in technologies to better address cancer, extend life, and ultimately reach a cure.
Steinman’s discovery of the dendritic cell won the Nobel Prize some years ago, and Dr. Liau’s work built upon his discovery and led to the discovery of how the dendritic cell-based technology can extend life for the deadliest cancer known to humankind. Dr. Liau deserves a Nobel Prize for her work and has already earned a worldwide reputation as an immunotherapy pioneer and scientific genius.
https://www.livescience.com/16354-nobel-prize-medicine-2011-immune-research.html
Dr. Liau is building upon the discoveries of scientists who have preceded her in time, and she is enlightening the future of immunotherapy with her groundbreaking work.
“I will respect the hard-won scientific gains of those physicians in whose steps I walk, and gladly share such knowledge as is mine with those who are to follow.” —Hippocratic Oath
https://soc-neuro-onc.org/
https://virtualtrials.org/dcvax.cfm
https://connect.uclahealth.org/2022/09/14/brain-cancer-discovery-clinical-trials/
https://www.fda.gov/science-research/advancing-regulatory-science/fda-nih-joint-leadership-council-charter
https://connect.uclahealth.org/2021/03/22/ucla-received-590-million-in-nih-funding-second-highest-total-for-academic-medical-centers-in-2020/
https://www.fda.gov/about-fda/fda-organization/richard-pazdur
https://www.annalsofoncology.org/article/S09237534(22)00006-0/fulltext
https://www.fda.gov/drugs/news-events-human-drugs/50-years-progress-treating-patients-cancer
https://www.webmd.com/cancer/cancer-in-context/video/richard-pazdur
https://www.onclive.com/view/pazdur-followed-the-pathway-of-greatest-resistance-to-the-fda
Immunotherapy will address a global need for less toxic and more efficacious cancer treatment. FDA believes without question that cell-based science is worthy of their support and will ensure that the United States will lead the world in technologies to better address cancer, extend life, and ultimately reach a cure.
Steinman’s discovery of the dendritic cell won the Nobel Prize some years ago, and Dr. Liau’s work built upon his discovery and led to the discovery of how the dendritic cell-based technology can extend life for the deadliest cancer known to humankind. Dr. Liau deserves a Nobel Prize for her work and has already earned a worldwide reputation as an immunotherapy pioneer and scientific genius.
https://www.livescience.com/16354-nobel-prize-medicine-2011-immune-research.html
Dr. Liau is building upon the discoveries of scientists who have preceded her in time, and she is enlightening the future of immunotherapy with her groundbreaking work.
“I will respect the hard-won scientific gains of those physicians in whose steps I walk, and gladly share such knowledge as is mine with those who are to follow.” —Hippocratic Oath
https://soc-neuro-onc.org/
https://virtualtrials.org/dcvax.cfm
https://connect.uclahealth.org/2022/09/14/brain-cancer-discovery-clinical-trials/
https://www.fda.gov/science-research/advancing-regulatory-science/fda-nih-joint-leadership-council-charter
https://connect.uclahealth.org/2021/03/22/ucla-received-590-million-in-nih-funding-second-highest-total-for-academic-medical-centers-in-2020/
https://www.fda.gov/about-fda/fda-organization/richard-pazdur
https://www.annalsofoncology.org/article/S09237534(22)00006-0/fulltext
https://www.fda.gov/drugs/news-events-human-drugs/50-years-progress-treating-patients-cancer
https://www.webmd.com/cancer/cancer-in-context/video/richard-pazdur
https://www.onclive.com/view/pazdur-followed-the-pathway-of-greatest-resistance-to-the-fda
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
